Sort
10,829 grants matching “car t”
Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapies
$1,481,031Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Optimization of genetic modification of HSCs in the NHP model and creation of relevant preclinical models of human disease and therapies
$1,481,031Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
$1,477,527David Jay Miklowitz · University Of California Los Angeles · R01 · FY2020 · MH
Genetic Engineering of Myeloid Cells to Treat Cancer
$1,476,000Julia C Carnevale · University Of California, San Francisco · DP2 · FY2025 · CA
CLINICAL DEVELOPMENT OF CAR T CELL THERAPY TARGETING CD70 IN PRIMARY GLIOBLASTOMA
$1,473,470University Of Florida · · FY2020 · Defense Health Agency
CPS:Medium: Tightly Integrated Perception and Planning in Intelligent Robotics
$1,473,121Mark E Campbell · Cornell University · · FY2009 · CSE
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,469,361Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies
$1,463,315Hunter Ramsdell Gibbons · Luminary Therapeutics, Inc. · R44 · FY2025 · CA
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$1,461,857Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
SCC-IRG Track 2: NeighborDrive: Community-driven Neighborhood Wellbeing Improvement through Active Vehicular Crowdsensing
$1,461,134Hae Young Noh · Stanford University · · FY2024 · CSE
Immunobiology and Immunotherapy of Pediatric Tumors
$1,459,080Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Harnessing natural killer cells for cellular immunotherapy against solid tumors
$1,457,050Wilfredo F Garcia-Beltran · Massachusetts General Hospital · DP2 · FY2025 · CA
Innovative approaches to enhance regulatory immune cell function and renal transplant survival in nonhuman primates
$1,455,073Angus W Thomson · University Of Pittsburgh At Pittsburgh · P01 · FY2025 · AI
Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumor treatment
$1,453,091Daniel J. Powell · University Of Pennsylvania · UG3 · FY2024 · CA
Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumor treatment
$1,453,091Daniel J. Powell · University Of Pennsylvania · UG3 · FY2025 · CA
Neural Coding of Visual Stimuli
$1,452,299Barry J Richmond · National Institute Of Mental Health · ZIA · FY2019 · MH
UCLA SPORE in Prostate Cancer
$1,449,094Robert E Reiter · University Of California Los Angeles · P50 · FY2020 · CA
Clinical Genome Resource (ClinGen) Informatics and Production Core
$1,447,800Carlos D. Bustamante · Stanford University · U41 · FY2020 · HG
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS at Northwestern University (C-THAN)
$1,447,142Robert L. Murphy · Northwestern University · U54 · FY2022 · EB
Targeting TEMs in Preclinical Tumor Models
$1,446,916Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
CAR T cell targeting of human islets
$1,446,086Seung K Kim · Stanford University · UC4 · FY2017 · DK
p53, Aging, and Cancer
$1,444,352Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
UCLA SPORE in Prostate Cancer
$1,443,180Robert E Reiter · University Of California Los Angeles · P50 · FY2021 · CA
Identification of cognitive decline and dementia: Prediction by everyday driving behaviors and physiological responses
$1,440,216Bruno Giordani · University Of Michigan At Ann Arbor · R01 · FY2022 · AG
Immunobiology and Immunotherapy of Pediatric Cancer
$1,440,159Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA